TR200102245T2 - Koroner müdahale ile ilgili kardiovasküler olayların önlenmesi veya azaltılması için yöntem. - Google Patents

Koroner müdahale ile ilgili kardiovasküler olayların önlenmesi veya azaltılması için yöntem.

Info

Publication number
TR200102245T2
TR200102245T2 TR2001/02245T TR200102245T TR200102245T2 TR 200102245 T2 TR200102245 T2 TR 200102245T2 TR 2001/02245 T TR2001/02245 T TR 2001/02245T TR 200102245 T TR200102245 T TR 200102245T TR 200102245 T2 TR200102245 T2 TR 200102245T2
Authority
TR
Turkey
Prior art keywords
preventing
events related
cardiovascular events
coronary intervention
reducing cardiovascular
Prior art date
Application number
TR2001/02245T
Other languages
English (en)
Turkish (tr)
Inventor
R. Granett Jeffrey
H. Shusterman Neil
C. U'prichard David
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of TR200102245T2 publication Critical patent/TR200102245T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TR2001/02245T 1999-02-03 2000-02-02 Koroner müdahale ile ilgili kardiovasküler olayların önlenmesi veya azaltılması için yöntem. TR200102245T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11846299P 1999-02-03 1999-02-03

Publications (1)

Publication Number Publication Date
TR200102245T2 true TR200102245T2 (tr) 2002-05-21

Family

ID=22378750

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/02245T TR200102245T2 (tr) 1999-02-03 2000-02-02 Koroner müdahale ile ilgili kardiovasküler olayların önlenmesi veya azaltılması için yöntem.

Country Status (17)

Country Link
EP (1) EP1171116A4 (ko)
JP (1) JP2002536327A (ko)
KR (1) KR20010101934A (ko)
CN (1) CN1345237A (ko)
AU (1) AU2636600A (ko)
BR (1) BR0007921A (ko)
CA (1) CA2361581A1 (ko)
CO (1) CO5150206A1 (ko)
HK (1) HK1045104A1 (ko)
HU (1) HUP0200129A3 (ko)
IL (1) IL144721A0 (ko)
MX (1) MXPA01007835A (ko)
NO (1) NO20013788L (ko)
PL (1) PL351397A1 (ko)
TR (1) TR200102245T2 (ko)
WO (1) WO2000045811A1 (ko)
ZA (1) ZA200106353B (ko)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2617407B2 (ja) * 1992-09-14 1997-06-04 キッセイ薬品工業株式会社 血管内膜細胞過剰増殖疾患の予防および治療剤
US5693337A (en) * 1994-07-13 1997-12-02 Wakamoto Pharmaceutical Co., Ltd. Stable lipid emulsion
KR19990044478A (ko) * 1995-09-07 1999-06-25 간자와 무츠와 2-아실아미노벤즈아미드 유도체 및 혈관내막세포 과잉증식에 기인하는 질환의 예방 및 치료제
US6019104A (en) * 1996-12-30 2000-02-01 Kissei Pharmaceutical Co., Ltd. Method for the treatment or prevention of restenosis associated with coronary intervention

Also Published As

Publication number Publication date
HUP0200129A3 (en) 2003-06-30
ZA200106353B (en) 2002-08-02
CO5150206A1 (es) 2002-04-29
BR0007921A (pt) 2002-09-10
CA2361581A1 (en) 2000-08-10
EP1171116A4 (en) 2004-11-17
JP2002536327A (ja) 2002-10-29
AU2636600A (en) 2000-08-25
MXPA01007835A (es) 2002-04-24
CN1345237A (zh) 2002-04-17
EP1171116A1 (en) 2002-01-16
PL351397A1 (en) 2003-04-07
NO20013788D0 (no) 2001-08-02
IL144721A0 (en) 2002-06-30
HUP0200129A2 (hu) 2002-05-29
WO2000045811A1 (en) 2000-08-10
HK1045104A1 (zh) 2002-11-15
NO20013788L (no) 2001-09-28
KR20010101934A (ko) 2001-11-15

Similar Documents

Publication Publication Date Title
BR9510168A (pt) Composto poliaminoácido composição forma unitária de dosagem e método par epreparar uma composição
CA2301017A1 (en) Use of propyl gallate to increase bioavailability of orally administered pharmaceutical compounds
JP2002531505A5 (ko)
SE9504661D0 (sv) New compounds
AU2003225617A1 (en) Thiadiazolylpiperazine derivatives useful for treating or preventing pain
KR930003912A (ko) 울혈성 심장 마비 치료법
ATE424810T1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
EA200200106A1 (ru) Фармацевтическая композиция леводопа/карбидопа/энтакапон
ATE260658T1 (de) Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen
TR200103613T2 (tr) Burun içinden tatbik edilen morfini içeren farmasötik formülasyonlar ve yöntemler.
RS54050B1 (en) FORMULATIONS AND METHODS FOR THE TREATMENT OF AMYLOIDOSIS
AR012853A1 (es) Formulacion inyectable transparente de compuesto anestesico
FI925801A (fi) Piperidyl-substituerade indoler
PT1039900E (pt) Agentes terapeuticos
EA200100947A1 (ru) Жевательные таблетки с высоким содержанием n-ацетилцистеина
EA199901116A1 (ru) Композиция, включающая 5-[4-[2-(n-метил-n-2-пиридил)-амино)этокси]бензил]тиазолидин-2,4-дион
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
TR200102245T2 (tr) Koroner müdahale ile ilgili kardiovasküler olayların önlenmesi veya azaltılması için yöntem.
TR200102087T2 (tr) Yeni morfolinbenzamid tuzları
GEP20043231B (en) Resorcinol Composition
TR200102262T2 (tr) Koroner müdahale ile ilgili kardiovasküler olayların önlenmesi veya azaltılması için yöntem.
JP2002500181A5 (ko)
TR200103704T2 (tr) Terapötik ajanlar
BR0012502A (pt) Inibidores da expressão do gene para interleucina 5
DE69615657T2 (de) Antifungal fusacandine